Spectrum Pharmaceuticals, Inc. Reports Fourth And Full Year 2013 Financial Results

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, announced today financial results for the three-month period and year ended December 31, 2013.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC